STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

Last updated:
2026-08-15
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE II STUDY OF STRIDE (DURVALUMAB + TREMELIMUMAB) WITH LENVATINIB VERSUS STRIDE ALONE IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA (STRIDE-HCC)

Intervention/treatment:
LENVIMA / IMFINZI / IMJUDO
Medical condition:
UNRESECTABLE HEPATOCELLULAR CARCINOMA
Protocol code:
HE.2
Control number:
296248
Status:
Recruiting
Approved:
April 30, 2025
Trial phase:
Phase 2
For more information:
ClinicalTrials.gov - NCT06880523
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Chris O'Callaghan
Role
CONTACT
Phone:
613-533-6430
Sponsor
CANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITY

Locations

Alberta

Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, T2N 5G2
Recruiting
Name
Vincent Tam
Role
CONTACT
Phone:
403 521-3706

British Columbia

BCCA - Kelowna
Kelowna, British Columbia, V1Y 5L3
Recruiting
Name
David Nguyen
Role
CONTACT
Phone:
250 712-3900
Extension 672699
BCCA - Vancouver
Vancouver, British Columbia, V5Z 4E6
Recruiting
Name
Howard Lim
Role
CONTACT
Phone:
604 877-6000
Extension 672699

Ontario

Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, L8V 5C2
Recruiting
Name
Shivani Dadwal
Role
CONTACT
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7
Recruiting
Name
Gordon Moffat
Role
CONTACT
Phone:
519 685-8500
London Health Sciences Centre Research Inc.
London, Ontario, N6A 5W9
Recruiting
Name
Elena Tsvetkova
Role
CONTACT
Phone:
519 685-8500
Ottawa Hospital Research Institute
Ottawa, Ontario, K1H 8L6
Recruiting
Name
Dominick Bosse
Role
CONTACT
Phone:
613 737-7700
Extension 35705
Trillium Health Partners - Credit Valley Hospital
Mississauga, Ontario, L5M 2N1
Recruiting
Name
Mala Bahl
Role
CONTACT
Phone:
416 521-4118
University Health Network
Toronto, Ontario, M5G 2M9
Recruiting
Name
Jennifer Knox
Role
CONTACT
Phone:
416 946-2399
Extension 35705
Waterloo Regional Health Network (WRHN)
Kitchener, Ontario, N2G 1G3
Recruiting
Name
Anupam Batra
Role
CONTACT
Phone:
519 685-8500

Quebec

CHUM-Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, H2X 3E4
Recruiting
Name
Helene Castel
Role
CONTACT
Phone:
514 890-8000
Extension 35705
The Jewish General Hospital
Montreal, Quebec, H3T 1E2
Recruiting
Name
Petr Kavan
Role
CONTACT
Phone:
514 398-1444

Saskatchewan

Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4
Recruiting
Name
Osama Ahmed
Role
CONTACT
Phone:
306 655-2662
Did you find what you were looking for?

Contacts and resources